Diagnosis & Treatment of Vitamin D Deficiency Seminar
Tuesday, December 2, 2008 8:00 am - 5:00 pm
Liebow Auditorium, University of California, San Diego
Attendee Registration fee is $45.00
Dear Colleague:
New vitamin D research is appearing daily! Does vitamin D really prevent cancer? Can it be used to treat it? What other diseases
might its deficiency contribute to? Hypertension? Type 1 diabetes? Multiple Sclerosis, osteoporosis, muscle weakness, infectious
diseases? Could these diseases be in large part 'deficiency' diseases? This seminar will address the latest information on what
we really know, what we don't, what current research is going on and what needs to be done. The focus is especially on what
practitioners can do to diagnose and treat any deficiency that exists today.
The seminar will be conducted by some of the country’s most notable vitamin D researchers and practitioners. Please review their information on our Faculty Site.
Target Audience
This course is designed for all health care personnel to address the vitamin
D deficiency with appropriate diagnosis and treatment.
Objectives
At the end of the course, the participants should be able to 1) List at least ten vitamin D sensitive diseases 2) Quantify
potential benefits of solving the vitamin D deficiency 3) Quantify a dose-response relationship for osteoporosis, falls/muscle
weakness in the elderly, type 1 diabetes and several cancers 4) Interpret the serum 25-hydroxyvitamin D test for
diagnostic and treatment measures (including the seasonal variation in measurements) 5) Identify and quantify any
risk categories for vitamin D treatment
Needs Assessment
The content of this educational activitiy was determined by assessment
of educational need and includes literature reviews, new research
publications (2007-08), interviews with researchers and practitioners and
public health professionals
Accreditation Statement
This activity has been planned and implemented in accordance with the
Essential Areas and policies of the Accreditation Council for continuing
Medical Education through the joint sponsorship of the University of
California, San Diego School of Medicine and GrassrootsHealth. The
University of California, San Diego School of Medicine is accredited by the
ACCME to provide continuing medical education for physicians.
The University of California, San Diego School of Medicine designates this
educational activity for a maximum of 6 AMA PRA Category 1 Credits™.
Physicians should only claim credit commensurate with the extent of their
participation in the activity.
Cultural and Linguistic Competency
This activity is in compliance with California Assembly Bill 1195 which
requires CME courses with patient care components to include curriculum
in the subjects of cultural and linguistic competencies. Cultural
competency is defined as a set of integrated attitudes, knowledge, and
skills that enable health care professionals or organizations to care
effectively for patients from diverse cultures, groups and communities.
Linguistic competency is defined as the ability of a physician or surgeon
to provide patients who do not speak English or who have limited ability
to speak English, direct communication in the patient’s primary language.
Cultural and Linguistic Competency was incorporated into the planning of
this activity. Additional resources on cultural and linguistic competency
and informaton about AB 1195 can be found on the UCSD CME website at
http://cme.ucsd.edu
Disclosure
It is the policy of the University of California, San Diego School of Medicine
to ensure balance, independence, objectivity and scientific rigor. All faculty
participating are required to disclose any real or apparent conflict of interest
related to the content of their presentation. All conflicts of interest will be
resolved prior to an educational activity being delivered to learners through
one of the following mechanisms 1) altering the financial relationship
with the commercial interest, 2) altering the individual’s control over CME
content about the products of services of the commercial interest, and/or 3)
validating the activity content through independent peer review. All faculty
are also required to disclose any discussions of off label/unapproved uses
of drugs or devices.